Syndrome douloureux pelvien chronique de l’adénomyose utérine: critères diagnostiques et traitement conservateur

Autor: D. Thiers-Bautrant, E. Bautrant, J. Eggermont, R. Boyer, H. Cassin, F. Itza, M.A. Bryselbout

Publikováno v: Pelvi-périnéologie. 6:42-45

Introduction| L’adenomyose est une cause frequente de douleur pelvienne chronique chez la femme. De 2001 a 2008, chez 270 patientes, ce syndrome de douleur pelvienne chronique a ete rattache a une adenomyose uterine par l’utilisation de criteres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7836e700073582b631ca2ff417ee6d0b
https://doi.org/10.1007/s11608-010-0355-5

Quantitative risk assessment for Escherichia coli O157:H7 in ground beef hamburgers

Autor: Anna M. Lammerding, R. S. Mccoll, Ewen C. D. Todd, M. H. Cassin, W.H. Ross

Publikováno v: International journal of food microbiology. 41(1)

Quantitative Risk Assessment (QRA) is a methodology used to organize and analyze scientific information to estimate the probability and severity of an adverse event. Applied to microbial food safety, the methodology can also help to identify those st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3d79119c8512d6e9b0bb48684260f25
https://pubmed.ncbi.nlm.nih.gov/9631335

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

How to Avoid Inadvertently Violating the Foreign Corrupt Business Practices Act Abroad.

Autor: Billings, B. Anthony, Crumbley, D. Larry, Knott, Cedric L.

Publikováno v: Journal of Forensic & Investigative Accounting. Jan-Jun2022, Vol. 14 Issue 1, p63-73. 11p.

Safety and protection of plasma donors: A scoping review and evidence gap map.

Autor: Schroyens N; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium., D'aes T; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium., De Buck E; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium., Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Tiberghien P; Etablissement Français du Sang, Saint-Denis, France.; Université de Franche-Comté, EFS, INSERM, UMR Right, Besançon, France., van den Hurk K; Donor Medicine Research - Donor Studies, Sanquin Research, Amsterdam, The Netherlands.; Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, The Netherlands., Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Compernolle V; Belgian Red Cross, Blood Services, Mechelen, Belgium.; Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium., Van Remoortel H; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Publikováno v: Vox sanguinis [Vox Sang] 2024 Feb; Vol. 119 (2), pp. 110-120. Date of Electronic Publication: 2023 Oct 10.